Dr. George A. (Jack) Cioffi is an internationally recognized glaucoma scientist and clinician and is the Edward S. Harkness Chairman and Ophthalmologist-in-Chief of the Department of Ophthalmology at New York Presbyterian Hospital/Columbia University Medical Center.
Dr. Cioffi presently holds the Jean and Richard Deems Professorship at Columbia University and formerly held the Richard Chenoweth Chair of Ophthalmology at the Devers Eye Institute. He was also the Chief Medical Officer & Senior Vice President at Legacy Health System in Portland, Oregon. He received his medical degree at the University of South Carolina, completed a residency in ophthalmology at the University of Maryland, and a fellowship in Research & Clinical Glaucoma at Devers Eye Institute under Dr. E. Michael Van Buskirk. More recently, he completed the inaugural Harvard Business School program in Managing Healthcare Delivery.
Dr. Cioffi received his undergraduate degree (magna cum laude and Phi Beta Kappa) from the University of Vermont and his medical degree (cum laude) from the University of South Carolina. He completed his residency at the University of Maryland, where he was chief resident. Since 2002, he has been listed among Castle Connolly's America's Top Doctors.
Dr. Cioffi has received numerous honors in his career, including the Clinician-Scientist Award from the American Glaucoma Society, the Senior Achievement Award from the American Academy of Ophthalmology, and the 2010 Shaffer-Hetherington-Hoskins award from the Glaucoma Research Foundation in San Francisco.
Chair, Department of Ophthalmology
Director, Edward S. Harkness Eye Institute
New York, NY
Dr. John is an Investigator of the Howard Hughes Medical Institute and Professor at The Jackson Laboratory. He is also a Research Assistant Professor in Ophthalmology at Tufts University School of Medicine and on the Graduate Faculty at the University of Maine. He received his B.Sc. degree - with joint honors in zoology and genetics - from University College, Cardiff, South Wales. He earned his PhD in Biology (studying human genetics) from McGill University, where he worked with Rima Rozen and Charles Scriver on the genetics of phenylketonuria. His postdoctoral training was with Nobel Laureate Oliver Smithies, at the University of North Carolina at Chapel Hill, studying genes contributing to essential hypertension.
Professor, The Jackson Laboratory
Investigator, Howard Hughes Medical Institute
Research Assistant Professor in Ophthalmology, Tufts University School of Medicine
Bar Harbor, ME
Dr. Rao is Professor of Ophthalmology and Pathology at the Keck School of Medicine and Director of Uveitis Service. He is involved in the treatment of inflammatory ocular diseases affecting the uveal tract, vitreous, retina and sclera. He has received numerous honors and awards for his research endeavors on ocular inflammatory diseases from Research to Prevent Blindness and the National Institute of Health. He delivered several named lectures including visiting professorship at Harvard University, Johns Hopkins University, Yale university, Washington university, University of California, San Francisco, University of Paris, France, Moorefields Eye Institute, London, University of Rome, Italy, Tokyo Medical University, Kyushu University in Fukoka , Japan and University of Sydney. Dr. Rao has published over 375 peer reviewed articles in the United States and in international journals, four books on ophthalmic diseases. For his outstanding contributions to Ophthalmology, he was awarded Lorenz E. Zimmerman medal from American Academy of Ophthalmology, Ramon L. Font medal from Pan American Society of Ophthalmology, International Ocular Inflammation Society Award and award from European Vision and Eye Research Association in 2006. Recently he was selected to receive a prestigious international medal, Bietti medal from International Council of Ophthalmology.
Professor of Ophthalmology
Director, Ophthalmic Pathology Laboratory and Uveitis Service
University of Southern California
Los Angeles, CA
Dr. Read was born in Nashville, TN and raised in Montgomery, AL. He received a Bachelor of Science Degree in Pharmacy from Auburn University in 1988. Following two years of pharmacy practice, he entered medical school at the University of Alabama School of Medicine, graduating magna cum laude in 1994. Dr. Read served an internship at Carraway Methodist Medical Center in Birmingham, and completed a residency in ophthalmology at the University of Washington, Seattle. He then spent two years at the Doheny Eye Institute/University of Southern California, completing dual fellowships in Uveitis/Ocular Inflammatory Diseases and Ophthalmic Pathology.
Dr. Read joined the full-time faculty of the UAB Department of Ophthalmology in August 2000. He is certified by the American Board of Ophthalmology and is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the American Uveitis Society, where he serves as Executive Secretary, the American Medical Association, the Medical Association of the State of Alabama, and the Alabama Academy of Ophthalmology. He is actively involved in clinical and applied basic science research.
Dr. Read's clinical practice and research focuses on uveitis and ocular inflammatory disease. In his research, Dr. Read’s goal is to understand the underlying reasons for health disparities among patients with uveitis. To accomplish this goal, current areas of focus are two fold. First, clinical data from patient care clinics is used to establish patient characteristics that predict worse disease severity and outcomes. Secondly, using an animal model of uveitis, Dr. Read is exploring the effect of melanin on disease severity. Dr. Read has authored or coauthored over 120 papers, book chapters, and abstracts.
Director, Uveitis/Ocular Inflammatory Disease Service
Professor of Ophthalmology and Pathology
Director Ophthalmology Residency Program
University of Alabama-Birmingham
Dr. Ip completed his medical studies at New York University's School of Medicine in 1993, before moving on in 1997 to an ophthalmology residency at the University of Pittsburgh's School Of Medicine and a fellowship in vitreoretinal surgery at Tufts University's New England Eye Center in 1999. Dr. Ip became a faculty member of the University of Wisconsin at Madison in 1999, where he is currently co-director of the Fundus Photograph Reading Center within the Department of Ophthalmology and Visual Sciences. He has been involved with numerous clinical trials and is the principal investigator of the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study.
Department of Ophthalmology and Visual Sciences
University of Wisconsin
Albert S. Jun, M.D., Ph.D., is the Maurice E. Langham, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in corneal disorders - including Fuchs dystrophy and keratoconus - refractive surgery (LASIK), cataracts and external eye diseases. Dr. Jun's clinical and research interests include endothelial keratoplasty, refractive surgery, genetic analysis of corneal diseases and corneal gene therapy.
Dr. Jun has received grants and awards from numerous organizations including the National Institutes of Health, the Heed Ophthalmic Foundation, the Eye Bank Association of America and the Association of University Professors of Ophthalmology.
Professor of Ophthalmology
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Andrew JW Huang, MD, MPH is a Professor of Ophthalmology and Visual Sciences at Washington University, St. Louis, MO. His research interests are ocular surface epithelial biology and molecular therapies for corneal dystrophies. He serves on the Editorial Board of Investigative Ophthalmology and Visual Science. Dr. Huang serves as a regular member of the NEI/NIH DPVS study section from 2013 to 2018 and a FDA consultant on Ophthalmic Devices Panel.
Professor of Ophthalmology and Visual Sciences
St Louis, MO
Dr. Cantor received his medical degree from the Indiana University (IU) School of Medicine in 1980. He completed his internship at the St. Vincent Health Care Center in Indianapolis, his residency at the IU department of ophthalmology and a glaucoma fellowship at the Wills Eye Hospital in Philadelphia.
Dr. Cantor joined the IU department of ophthalmology as the director of the glaucoma service in 1985. From 1986 to 1989, he also served as chief of ophthalmology at Wishard Memorial Hospital in Indianapolis. In 1996, he assumed an additional role as director of the ophthalmology residency program for the department. In 1999, he attained the rank of professor of ophthalmology and in 2009 was named chairman of the department of ophthalmology.
In his years with the department, Dr. Cantor has made significant contributions to the research, patient care and education mission of the IU department of ophthalmology. Dr. Cantor is recognized as one of the leading experts in evaluating new topical medications in glaucoma. He created and developed an extremely successful clinical research program and has received more than 30 grants and fellowships to fund his research. He and his colleague, Alon Harris, PhD, developed the Glaucoma Research and Diagnostic Center, a state-wide referral center that has become the leading facility internationally for evaluating the effects of ocular blood flow. While at Wishard Hospital, Dr. Cantor established a strong residency training program and patient care service that remains a central part of the department’s current ophthalmology residency program.
Dr. Cantor is the author of 85 articles on all aspects of ophthalmology and has given more than 250 lectures and presentations worldwide on the diagnostic and medical and surgical aspects of glaucoma care. In addition, Dr. Cantor is an active member of numerous national eye organizations, including the American Ophthalmological Society, Association for Research in Vision and Ophthalmology and the Association of University Professors of Ophthalmology. At the Academy, Dr. Cantor served on the Glaucoma BCSC committee for 10 years as a member and chair of the committee, before assuming the leadership of the BCSC. In January 2007, Dr. Cantor became the Academy's secretary for education. He has been an associate and senior associate examiner of the American Board of Ophthalmology and served as treasurer of the American Glaucoma Society. He is a former member and chair of the Residency Review Committee for Ophthalmology and also served as chair of the Council of Review Committee Chairs, on the Executive Committee and the Strategic Initiatives Committee, Committee on Innovation in the Learning Environment, and ad hoc Committee on Non-Governmental Funding of Graduate Medical Education for the Accreditation Council for Graduate Medical Education. Dr. Cantor currently serves on the editorial review boards of several ophthalmology journals.
Professor and Chair, Eugene and Marilyn Glick Eye Institute
Newly appointed to the faculty of SUNY Downstate in Ophthalmology and Cell Biology, Dr. Danias is a prominent glaucoma specialist who completed a research fellowship in glaucoma and a clinical opthalmology fellowship at Mt. Sinai Medical Center where he remained for ten years. He has been the recipient of multiple NIH/National Eye Institute research grants as well as grants from the Research to Prevent Blindness Foundation. His work has been presented nationally and internationally, and he is a very sought after invited speaker for both the basic and clinical aspects of glaucoma.
Professor of Ophthalmology and Cell Biology
Co-Director of the Glaucoma Service
Department of Ophthalmology
SUNY Downstate Medical Center
Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, macular degeneration, macular holes, macular pucker, diabetic retinopathy, and intraocular inflammation. He has published more than 250 articles and book chapters and 7 books about the diagnosis and treatment of retinal diseases. He has given lectures around the world.
He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.
He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Ophthalmology and the Prix Soubrane de la Recherche en Ophthalmologie. Dr. Spaide is on medical boards of a number of institutions and has been mentioned in multiple Who’s Who and Best Doctors lists. He is a past executive editor of the American Journal of Ophthalmology and is currently associate editor of the journal Retina. He is on the editorial board of numerous journals.
Vitreous-Retina-Macula Consultants of New York
New York, NY
Dr. Curcio is professor of ophthalmology, Eminent Scholar in Retina, and director of the AMD Histopathology Lab. She also serves as scientific director of the Alabama Eye Bank. Capitalizing on the eye bank as a resource, her research focuses on aging, age-related macular degeneration with emphasis on pathobiology, image validation through histology, and collaborative genomics studies.
Dr. Curcio has authored or co-authored more than 90 journal articles and has presented abstracts at vision meetings every year since 1985. She has given around 150 invited lectures at major meetings, congresses and universities in North America and Europe. Dr. Curcio serves on the editorial boards of Investigative Ophthalmology & Visual Science, Current Eye Research and Progress in Retinal and Eye Research. She serves as permanent member of the Board of Scientific Counselors of the National Eye Institute, and starting in February 2014 she serves as a charter member of Disease and Pathology of Visual Study section.
Her research has been funded by the National Eye Institute, Research to Prevent Blindness, International Retinal Research Foundation, Edward N. and Della L. Thome Memorial Foundation Awards Program, Arnold and Mabel Beckman Initiative for Macular Research, Macula Vision Research Foundation, and industry.
Dr. Curcio obtained her undergraduate degree in biology from Brown University in 1972. She attended graduate school at the University of Wisconsin-Madison and received a Ph.D. in anatomy from the University of Rochester in 1981 under the supervision of Paul Coleman, Ph.D. After post-doctoral work at the Boston University School of Medicine with James Hinds, Ph.D., she spent six years at the University of Washington in Seattle, where she began anatomical studies of the human retina that are now widely cited, in the laboratory of Anita Hendrickson, Ph.D. In 1990, Dr. Curcio joined the UAB Department of Ophthalmology, where she is now a professor.
Dr. Curcio has been awarded the University of Washington School of Medicine, Science in Medicine - New Investigator (1988), the Roger H. Johnson Prize in Macular Degeneration Research from University of Washington (2002), Association for Research in Vision and Ophthalmology Silver Fellow (2009) and Gold Fellow (2010), and the Prix Soubrane de la Recherche en Ophtalmologie (2011).
University of Alabama Birmingham
Department of Ophthalmology